Featured molecule

Publications

Founded in 2006, q.e.d. life sciences aims to combine into a cutting- edge technology platform systems level target identification with molecular-level directed evolution and advanced drug target crystal-lography as basis for structure guided drug discovery methods. Combination of genetic methods which structure based lead discovery enables us to rapidly translate initial leads into robust and resistance-resistant therapeutic drug candidates. Licensed products include proprietary protein drug target crystallography automation technologies.

President and Founder
Dr. Bernhard Rupp, Drug Target Crystallography and Drug Discovery

Board of Directors

Advisory Board

EvoTheRx Evolutionary Therapeutics

Advanced Drug Target Crystallography Automation 


TECHNOLOGIES

CONTRACT RESEARCH
CONSULTING
EvoTheRX THERAPEUTICS
PARTNERS
 

Robotic Crystal Harvesting

q.e.d. life science discoveries, inc., is a closely held California stock corporation

 

 Micro Crystallization Movie (WMV)

 Workshops     CrysCam     Licensing


Telephone: 925-209-7429 • The entire site © 2005-2015 by q.e.d. life science discoveries, inc., California, USA..  All rights reserved.